These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2993947)

  • 1. Intracerebroventricular administration of cholecystokinin inhibits the activity of the dopaminergic and serotoninergic systems of the brain.
    Vasar EE; Otter MYa ; Ryago LK
    Neurosci Behav Physiol; 1985; 15(3):232-6. PubMed ID: 2993947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intracerebroventricular administration of cholecystokinin inhibits the dopamine- and serotoninergic systems of the brain].
    Vasar EE; Otter MIa; Riago LK
    Fiziol Zh SSSR Im I M Sechenova; 1982 Sep; 68(9):1218-22. PubMed ID: 7173435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional studies of cholecystokinin-dopamine co-existence: electrophysiology and behavior.
    Skirboll LR; Crawley JN; Hommer DW
    Prog Brain Res; 1986; 68():357-70. PubMed ID: 3562851
    [No Abstract]   [Full Text] [Related]  

  • 5. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms.
    Harrison AA; Everitt BJ; Robbins TW
    Psychopharmacology (Berl); 1997 Oct; 133(4):329-42. PubMed ID: 9372531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
    Quik M; Sourkes TL
    J Neurochem; 1977 Jan; 28(1):137-47. PubMed ID: 13151
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of cholecystokinin on apomorphine-induced changes of motility in rats.
    Katsuura G; Itoh S; Rehfeld JF
    Neuropharmacology; 1984 Jul; 23(7A):731-4. PubMed ID: 6089021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of 5-hydroxy-N-acetyltryptophan, a putative synthetic precursor of N-acetylserotonin.
    Burns TG; Szechtman H; Brown GM; Snieckus V
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):359-63. PubMed ID: 6984517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural and ECoG spectrum power effects after intraventricular injection of drugs altering dopaminergic transmission in rats.
    Bagetta G; Corasaniti MT; Strongoli MC; Sakurada S; Nisticò G
    Neuropharmacology; 1987 Aug; 26(8):1047-52. PubMed ID: 2889160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats.
    Morency MA; Ross GM; Hesketh D; Mishra RK
    Peptides; 1987; 8(6):989-95. PubMed ID: 3441450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central monoaminergic effects of two aporphine analogues to the putative serotonin-receptor agonist, 8-hydroxy-2-di-n-propylaminotetralin.
    Hjorth S; Neumeyer JL
    Neuropharmacology; 1984 Oct; 23(10):1187-90. PubMed ID: 6097834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cholecystokinin on thyrotropin releasing hormone (TRH)-induced serotonin potentiation in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(1):145-8. PubMed ID: 6281503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat.
    Wunderlich GR; DeSousa NJ; Vaccarino FJ
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):283-90. PubMed ID: 10972475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of brain serotonin and dopamine in controlling male sexual behavior.
    Gessa GL; Tagliamonte A
    Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859
    [No Abstract]   [Full Text] [Related]  

  • 15. Ascorbate antagonizes the behavioral effects of amphetamine by a central mechanism.
    White LK; Carpenter M; Block M; Basse-Tomusk A; Gardiner TW; Rebec GV
    Psychopharmacology (Berl); 1988; 94(2):284-7. PubMed ID: 2832869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a modulatory influence of centrally administered substance P on a 5-hydroxytryptamine-mediated behavioural response in the male rat.
    Ogren SO; Fuxe K; Agnati LF
    Acta Physiol Scand; 1985 Dec; 125(4):743-5. PubMed ID: 2418636
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of large doses of phenamine after previous administration of 5-hydroxytryptophan and para-chlorophenylalanine on the spontaneous behavior of cats and the effects induced by caudate nucleus stimulation].
    Arushanian EB; Tolpyshev BA
    Farmakol Toksikol; 1979; 42(2):106-12. PubMed ID: 220082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On some relationships between dopaminergic and serotoninergic mechanisms in pentylenetetrazol convulsions in albino mice.
    Lazarova M; Roussinov K
    Acta Physiol Pharmacol Bulg; 1979; 5(3):67-74. PubMed ID: 317212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T; Fekete M; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarification of the behavioral functions of peripheral and central cholecystokinin: two separate peptide pools.
    Crawley JN
    Peptides; 1985; 6 Suppl 2():129-36. PubMed ID: 3001671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.